| Product Code: ETC13206849 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Viral Gastroenteritis Market was valued at USD 1.3 Billion in 2024 and is expected to reach USD 1.9 Billion by 2031, growing at a compound annual growth rate of 6.20% during the forecast period (2025-2031).
The Global Viral Gastroenteritis Market is experiencing steady growth due to the increasing prevalence of viral gastroenteritis cases worldwide. Factors such as poor sanitation, contaminated food and water sources, and lack of proper hygiene practices contribute to the spread of viral gastroenteritis. The market is driven by the rising demand for effective diagnostic tests, antiviral medications, and vaccines to manage and prevent viral gastroenteritis infections. Key players in the market are focusing on research and development activities to introduce innovative treatment options and improve patient outcomes. The market is expected to witness further growth with the increasing awareness about the disease, advancements in healthcare infrastructure, and government initiatives to control the spread of viral gastroenteritis.
The Global Viral Gastroenteritis Market is experiencing significant growth due to the increasing prevalence of viral gastroenteritis worldwide. Key trends include the rising adoption of oral rehydration solutions for managing symptoms, the development of novel antiviral therapies, and the focus on improving diagnosis and treatment options. Opportunities in the market lie in the expansion of healthcare infrastructure in developing regions, the growing awareness about the importance of hygiene and sanitation practices in preventing viral gastroenteritis, and the potential for collaborations between pharmaceutical companies and research institutions to drive innovation in treatment modalities. Overall, the market is poised for continued growth as efforts are made to address the burden of viral gastroenteritis and improve patient outcomes globally.
The Global Viral Gastroenteritis Market faces several challenges, including lack of awareness about the disease in developing regions, limited availability of specific antiviral treatments, and the high cost of healthcare services in some countries. Additionally, the rapid mutation rate of the viruses causing gastroenteritis poses a challenge in developing effective vaccines and treatment options. Furthermore, the global outbreak of infectious diseases such as the COVID-19 pandemic has diverted resources and attention away from research and development efforts for viral gastroenteritis. These challenges hinder the market`s growth potential and limit the accessibility of effective treatment options for patients worldwide. Addressing these challenges will require collaborative efforts among healthcare providers, researchers, and policymakers to improve awareness, access to care, and innovative treatment solutions for viral gastroenteritis.
The global viral gastroenteritis market is primarily driven by the increasing prevalence of viral gastroenteritis worldwide. The growing awareness about the disease, advancements in diagnostic technologies, and rising healthcare expenditure are also contributing to market growth. Additionally, the development of novel treatment options, such as antiviral medications and vaccines, is expected to fuel market expansion. Furthermore, the emphasis on preventive measures, such as improved sanitation practices and hygiene awareness campaigns, is playing a crucial role in driving the market forward. The increasing research and development activities focused on understanding the various strains of viruses causing gastroenteritis and developing effective treatment strategies are further propelling market growth. Overall, the rising incidence of viral gastroenteritis and the concerted efforts to address this public health concern are key drivers shaping the global market landscape.
Government policies related to the Global Viral Gastroenteritis Market primarily focus on public health measures to prevent and control the spread of viral gastroenteritis. These policies often include regulations for sanitation and food safety to reduce the risk of infection, as well as guidelines for healthcare providers on diagnosis and treatment. Additionally, some governments may have vaccination programs in place to prevent specific types of viral gastroenteritis. Funding for research and development of vaccines and treatments, as well as public awareness campaigns, are also common components of government policies in this market. Overall, the objective of these policies is to minimize the burden of viral gastroenteritis on public health and healthcare systems.
The Global Viral Gastroenteritis Market is expected to experience steady growth in the coming years, driven by factors such as increasing awareness about the disease, advancements in diagnostic technologies, and growing healthcare expenditure worldwide. The market is likely to witness a rise in the demand for antiviral medications, vaccines, and supportive care products to manage and treat viral gastroenteritis effectively. Additionally, the rising prevalence of viral gastroenteritis due to factors like poor sanitation and hygiene practices in developing countries is expected to further boost market growth. The market players are focusing on research and development activities to introduce innovative treatment options and expand their product portfolios, which will contribute to the market`s expansion in the future. However, stringent regulatory requirements and the availability of alternative treatment options may pose challenges to market growth.
In the global viral gastroenteritis market, Asia is expected to witness significant growth due to the high prevalence of viral infections in countries like India and China. North America and Europe are also key regions, with advanced healthcare infrastructure driving market growth. The Middle East and Africa region is projected to show steady growth, driven by improving healthcare facilities and increasing awareness about viral gastroenteritis. Latin America is anticipated to experience moderate growth, as the region faces challenges in healthcare access and awareness. Overall, the global viral gastroenteritis market is likely to see substantial growth opportunities in these regions, with increasing focus on preventive measures and effective treatment options.
Global Viral Gastroenteritis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Viral Gastroenteritis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Viral Gastroenteritis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Viral Gastroenteritis Market - Industry Life Cycle |
3.4 Global Viral Gastroenteritis Market - Porter's Five Forces |
3.5 Global Viral Gastroenteritis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Viral Gastroenteritis Market Revenues & Volume Share, By Type Of Virus, 2021 & 2031F |
3.7 Global Viral Gastroenteritis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Global Viral Gastroenteritis Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.9 Global Viral Gastroenteritis Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.10 Global Viral Gastroenteritis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Viral Gastroenteritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Viral Gastroenteritis Market Trends |
6 Global Viral Gastroenteritis Market, 2021 - 2031 |
6.1 Global Viral Gastroenteritis Market, Revenues & Volume, By Type Of Virus, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Viral Gastroenteritis Market, Revenues & Volume, By Norovirus, 2021 - 2031 |
6.1.3 Global Viral Gastroenteritis Market, Revenues & Volume, By Rotavirus, 2021 - 2031 |
6.1.4 Global Viral Gastroenteritis Market, Revenues & Volume, By Astrovirus, 2021 - 2031 |
6.1.5 Global Viral Gastroenteritis Market, Revenues & Volume, By Enteric Adenovirus, 2021 - 2031 |
6.2 Global Viral Gastroenteritis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Viral Gastroenteritis Market, Revenues & Volume, By Physical Examination, 2021 - 2031 |
6.2.3 Global Viral Gastroenteritis Market, Revenues & Volume, By Rapid Stool Test, 2021 - 2031 |
6.3 Global Viral Gastroenteritis Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Viral Gastroenteritis Market, Revenues & Volume, By Antibiotics, 2021 - 2031 |
6.3.3 Global Viral Gastroenteritis Market, Revenues & Volume, By Antacids, 2021 - 2031 |
6.3.4 Global Viral Gastroenteritis Market, Revenues & Volume, By Laxatives, 2021 - 2031 |
6.3.5 Global Viral Gastroenteritis Market, Revenues & Volume, By Antimotility Agents, 2021 - 2031 |
6.3.6 Global Viral Gastroenteritis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3.7 Global Viral Gastroenteritis Market, Revenues & Volume, By Antiemetics, 2021 - 2031 |
6.3.8 Global Viral Gastroenteritis Market, Revenues & Volume, By Chemotherapy Drugs, 2021 - 2031 |
6.4 Global Viral Gastroenteritis Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Viral Gastroenteritis Market, Revenues & Volume, By Watery Diarrhea, 2021 - 2031 |
6.4.3 Global Viral Gastroenteritis Market, Revenues & Volume, By Vomiting, 2021 - 2031 |
6.4.4 Global Viral Gastroenteritis Market, Revenues & Volume, By Abdominal Cramps and Pain, 2021 - 2031 |
6.4.5 Global Viral Gastroenteritis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Viral Gastroenteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Viral Gastroenteritis Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 Global Viral Gastroenteritis Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.5.4 Global Viral Gastroenteritis Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.5.5 Global Viral Gastroenteritis Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.5.6 Global Viral Gastroenteritis Market, Revenues & Volume, By Ambulatory Care Centers, 2021 - 2031 |
6.5.7 Global Viral Gastroenteritis Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Viral Gastroenteritis Market, Overview & Analysis |
7.1 North America Viral Gastroenteritis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Viral Gastroenteritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Viral Gastroenteritis Market, Revenues & Volume, By Type Of Virus, 2021 - 2031 |
7.4 North America Viral Gastroenteritis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.5 North America Viral Gastroenteritis Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.6 North America Viral Gastroenteritis Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.7 North America Viral Gastroenteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Viral Gastroenteritis Market, Overview & Analysis |
8.1 Latin America (LATAM) Viral Gastroenteritis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Viral Gastroenteritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Viral Gastroenteritis Market, Revenues & Volume, By Type Of Virus, 2021 - 2031 |
8.4 Latin America (LATAM) Viral Gastroenteritis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
8.5 Latin America (LATAM) Viral Gastroenteritis Market, Revenues & Volume, By Drugs, 2021 - 2031 |
8.6 Latin America (LATAM) Viral Gastroenteritis Market, Revenues & Volume, By Indication, 2021 - 2031 |
8.7 Latin America (LATAM) Viral Gastroenteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Viral Gastroenteritis Market, Overview & Analysis |
9.1 Asia Viral Gastroenteritis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Viral Gastroenteritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Viral Gastroenteritis Market, Revenues & Volume, By Type Of Virus, 2021 - 2031 |
9.4 Asia Viral Gastroenteritis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
9.5 Asia Viral Gastroenteritis Market, Revenues & Volume, By Drugs, 2021 - 2031 |
9.6 Asia Viral Gastroenteritis Market, Revenues & Volume, By Indication, 2021 - 2031 |
9.7 Asia Viral Gastroenteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Viral Gastroenteritis Market, Overview & Analysis |
10.1 Africa Viral Gastroenteritis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Viral Gastroenteritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Viral Gastroenteritis Market, Revenues & Volume, By Type Of Virus, 2021 - 2031 |
10.4 Africa Viral Gastroenteritis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
10.5 Africa Viral Gastroenteritis Market, Revenues & Volume, By Drugs, 2021 - 2031 |
10.6 Africa Viral Gastroenteritis Market, Revenues & Volume, By Indication, 2021 - 2031 |
10.7 Africa Viral Gastroenteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Viral Gastroenteritis Market, Overview & Analysis |
11.1 Europe Viral Gastroenteritis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Viral Gastroenteritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Viral Gastroenteritis Market, Revenues & Volume, By Type Of Virus, 2021 - 2031 |
11.4 Europe Viral Gastroenteritis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
11.5 Europe Viral Gastroenteritis Market, Revenues & Volume, By Drugs, 2021 - 2031 |
11.6 Europe Viral Gastroenteritis Market, Revenues & Volume, By Indication, 2021 - 2031 |
11.7 Europe Viral Gastroenteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Viral Gastroenteritis Market, Overview & Analysis |
12.1 Middle East Viral Gastroenteritis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Viral Gastroenteritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Viral Gastroenteritis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Viral Gastroenteritis Market, Revenues & Volume, By Type Of Virus, 2021 - 2031 |
12.4 Middle East Viral Gastroenteritis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
12.5 Middle East Viral Gastroenteritis Market, Revenues & Volume, By Drugs, 2021 - 2031 |
12.6 Middle East Viral Gastroenteritis Market, Revenues & Volume, By Indication, 2021 - 2031 |
12.7 Middle East Viral Gastroenteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Viral Gastroenteritis Market Key Performance Indicators |
14 Global Viral Gastroenteritis Market - Export/Import By Countries Assessment |
15 Global Viral Gastroenteritis Market - Opportunity Assessment |
15.1 Global Viral Gastroenteritis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Viral Gastroenteritis Market Opportunity Assessment, By Type Of Virus, 2021 & 2031F |
15.3 Global Viral Gastroenteritis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
15.4 Global Viral Gastroenteritis Market Opportunity Assessment, By Drugs, 2021 & 2031F |
15.5 Global Viral Gastroenteritis Market Opportunity Assessment, By Indication, 2021 & 2031F |
15.6 Global Viral Gastroenteritis Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Viral Gastroenteritis Market - Competitive Landscape |
16.1 Global Viral Gastroenteritis Market Revenue Share, By Companies, 2024 |
16.2 Global Viral Gastroenteritis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here